Skip to main content
Nuuron logo

Nuuron

Berlin, GermanyFounded 2023

  • Seed

Nuuron is an emerging company with a website currently under development. Limited public information is available about its products, services, market, or mission.

Raised
$3.8M
Oct 2024
Seed
Investors
5
Founded
2023
Employees
1–10

reccy insights

Recent highlights

Nuuron’s clearest financing milestone was its €3.5 million seed round, announced on Oct 31, 2024, equivalent to approximately $3.81 million. HTGF (High-Tech Gruenderfonds) led the round, with IBB Ventures, Business Angels Club Berlin-Brandenburg e.V., Caesar Ventures, and Kinled Holding also participating. The financing supports a company founded in 2023 and developing the Memory-Pacemaker, described as a non-invasive photonic neurostimulation device intended to help people with Alzheimer’s store and retrieve memories. Nuuron also appeared in a 2025 European healthtech startups-to-watch feature published on Jun 4, 2025, providing a visibility milestone rather than evidence of a product launch or clinical result. Patent-related activity includes filings or publications dated Mar 13, 2023 and Mar 13, 2024 concerning devices and methods for inducing high-frequency brain oscillations. The company’s profile lists one granted patent and one registered trademark.

Written by reccy's AI from company sites, press and funding records · updated Oct 2026

Technology & products

  • Memory-Pacemaker

    A non-invasive photonic neurostimulation device intended to help people with Alzheimer’s store and retrieve memories.

Funding

$3.8M disclosed
5 investors

About Nuuron

Products
Memory-Pacemaker
Leadership
Fabian Queisner, Co-Founder & CEO
Focus areas
NeuroTechnology, biotechnology, science and engineering
Headquarters
Berlin, Germany
Founded
2023
Employees
1–10
Patents granted
1
Trademarks
1